EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $217,654 | -5.0% | 7,672 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $229,134 | -99.9% | 7,839 | -49.4% | 0.00% | 0.0% |
| Q3 2022 | $205,205,000 | +59552.6% | 15,502 | +100.2% | 0.00% | -50.0% |
| Q2 2022 | $344,000 | -9.5% | 7,743 | +0.9% | 0.00% | 0.0% |
| Q1 2022 | $380,000 | -4.3% | 7,677 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $397,000 | -8.7% | 7,796 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | +30.6% | 7,794 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $333,000 | +1.5% | 7,791 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $328,000 | -6.0% | 7,867 | +4.8% | 0.00% | 0.0% |
| Q4 2020 | $349,000 | -99.9% | 7,505 | +7047.6% | 0.00% | -33.3% |
| Q3 2020 | $310,000,000 | – | 105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 121,014 | $5,377,000 | 1.78% |
| Smith, Graham & Co., Investment Advisors, LP | 232,343 | $10,323,000 | 1.28% |
| GLOBEFLEX CAPITAL L P | 73,205 | $3,252,000 | 0.79% |
| SummerHaven Investment Management, LLC | 18,604 | $827,000 | 0.56% |
| BRANDES INVESTMENT PARTNERS, LP | 464,292 | $20,628,000 | 0.50% |
| Capital Impact Advisors, LLC | 11,728 | $521,000 | 0.48% |
| Watershed Asset Management, L.L.C. | 5,756 | $256,000 | 0.32% |
| Foundry Partners, LLC | 84,325 | $3,747,000 | 0.23% |
| Summit Global Investments | 33,738 | $1,499,000 | 0.13% |
| SCOUT INVESTMENTS, INC. | 147,034 | $6,533,000 | 0.13% |